It seems like a best-kept secret that managing investigator payments is probably one of the most challenging aspects of conducting a clinical trial.
Proper protocol development is critical to ensure the reproducibility of trial results, especially in pandemic emergencies such as the COVID-19 era.
Pharmaceutical industry interest is growing about how to apply Bayesian statistics to research, development, manufacturing, and health economics.
Can a “big swings of bold” philosophy drive innovation in the clinical research enterprise? One expert strategist thinks so.
If we can solve the challenge of underrepresentation in research, we can change the trajectory of peoples’ lives for the better.